A systematic review of the cost-effectiveness of interventions for supporting informal caregivers of people with dementia residing in the community

International Psychogeriatrics

Volumn 24, Issue 1, 2012, Pages 6-18

  Jones, Carys ^a   Edwards, Rhiannon Tudor ^a   Hounsome, Barry ^a  

^a BANGOR UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; carers; health economics; measurement; quality of life

Indexed keywords

CAREGIVER; COMMUNITY LIVING; COST EFFECTIVENESS ANALYSIS; DATA BASE; DEMENTIA; ECONOMIC EVALUATION; HUMAN; RESIDENTIAL AREA; REVIEW; SYSTEMATIC REVIEW;

CAREGIVERS; COST-BENEFIT ANALYSIS; DEMENTIA; HEALTH CARE COSTS; HUMANS; NOOTROPIC AGENTS; RESPITE CARE;

EID: 82055169081     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610211001207     Document Type: Review

References (26)

1. Barrett, A., Roques, T., Small, M. and Smith, R. D. (2006). Rationing: how much will Herceptin really cost? BMJ, 333, 1188-1120.
2. Brodaty, H., Green, A. and Koschera, A. (2003). Meta-analysis of psychosocial interventions for caregivers of people with dementia. Journal of the American Geriatrics Society, 51, 657-664. (Pubitemid 36541430)
3. Challis, D., von Abendorff, R., Brown, P., Chesterman, J. and Hughes, J. (2002). Care management, dementia care and specialist mental health services: an evaluation. International Journal of Geriatric Psychiatry, 17, 315-325. (Pubitemid 34467089)
4. Charlesworth, G., Shepstone, L., Wilson, E., Thalanany, M., Mugford, M. and Poland, F. (2008). Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost? A randomised controlled trial, Health Technology Assessment, 12 (4), 1-78.
5. Courtney, C. et al. (2004). Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet, 363, 2105-2115.
6. Department of Health (2010). Recognised, Valued and Supported: Next Steps for the Carers Strategy. London: Department of Health.
7. Drummond, M., Mohide, E., Tew, M., Streiner, D., Pringle, D. and Gilbert, J. (1991). Economic evaluation of a support program for caregivers of demented elderly. International Journal of Technology Assessment in Health Care, 7, 2, 209-219.
8. Drummond, M., Sculpher, M., Torrance, G. W., O'Brien, B. J. and Stoddart, G. L. (2005). Methods for the Economic Evaluation of Health Care Programmes, 3rd edn, Oxford University Press.
9. Engelhardt, J. B., Kisiel, T., Nicholson, J., Mulichak, L., DeMatteis, J. and Tobin, D. R. (2008). Impact of a care coordination and support strategic partnership on clinical outcomes. Home Healthcare Nurse, 26, 3,166-172.
10. Feldman, H. et al. (2003). Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. Journal of the American Geriatrics Society, 51, 737-744. (Pubitemid 36693421)
11. Feldman, H. et al. (2004). Economic evaluation of donepezil in moderate to severe Alzheimer disease. Neurology, 63, 644-650. (Pubitemid 39100819)
12. Gaugler, J. E., Zarit, S. H., Townsend, A., Stephens, M-A., P. and Greene, R. (2003). Evaluating community-based programs for dementia caregivers: the cost implications of adult day services. Journal of Applied Gerontology, 22, 118-133. (Pubitemid 36297872)
13. Getsios, D., Blume, S., Ishak, K. J. and Maclaine, G. D. (2010). Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation. PharmacoEconomics, 28, 411-427.
14. Graff, M. J. L., Vernooij-Dassen, M. J. M., Thijssen, M., Dekker, J., Hoefnagels, W. H. L. and Rikkert, M. G. M. O. (2006). Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial. BMJ, 333, 7580, 1196.
15. Graff, M. J. L. et al. (2008). Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. BMJ, 336, 7636, 134-138. (Pubitemid 351216996)
16. Joling, K. J. et al. (2008). (Cost)-effectiveness of family meetings on indicated prevention of anxiety and depressive symptoms and disorders of primary family caregivers of patients with dementia: design of a randomized controlled trial. BMC Geriatrics, 8, 2.
17. Luengo-Fernandez, R., Leal, J. and Gray, A. (2010). Dementia 2010. The Economic Burden of Dementia and Associated Research Funding in the United Kingdom. Cambridge: Alzheimer's Research Trust.
18. Martikainen, J., Valtonen, H. and Pirttila, T. (2004). Potential cost-effectiveness of a family-based program in mild Alzheimer's disease patients. Health Economics in Prevention and Care, 5, 136-142. (Pubitemid 38832956)
19. Neumann, P. J. et al. (1999). Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology, 52, 1138-1145. (Pubitemid 29177912)
20. NICE (2007). Dementia: Supporting People with Dementia and their Carers in Health and Social Care. London: National Institute for Health and Clinical Excellence and Social Care Institute for Excellence.
21. NICE (2008). Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence.
22. NICE (2009). Donepezil, Galantamine, Rivastigmine (Review) and Memantine for the Treatment of Alzheimer's Disease (Amended). London: National Institute for Health and Clinical Excellence.
23. Roberts, J. et al., (1999). Problem-solving counseling for caregivers of the cognitively impaired: effective for whom? Nursing Research, 48, 162-172.
24. Wilson, E. et al. (2009). Befriending carers of people with dementia: a cost utility analysis, International Journal of Geriatric Psychiatry, 24, 610-623.
25. Wimo, A. and Prince, M. (2010). Alzheimer's Disease International World Alzheimer Report 2010: The Global Economic Impact of Dementia, London: Alzheimer's Disease International.
26. Woods, R. T. et al. (2009). Reminiscence groups for people with dementia and their family carers: pragmatic eight-centre randomised trial of joint reminiscence and maintenance versus usual treatment: a protocol. Trials, 10, 64.